Ferritin analogs |
| Despite the fact that ferritin is extremely selective in accumulating, storing and dispensing iron ... |
|
Methods of treatment using anti-ErbB antibody-maytansinoid conjugates |
| What is claimed is: 1. A method for the treatment of a tumor in a mammal, comprising the steps of (... |
|
Methods for diagnosing early Lyme disease |
| This invention is based upon the discovery that sera from patients with early Lyme disease contain ... |
|
Tango 243 polypeptides and uses thereof |
| The present invention is based, at least in part, on the discovery of cDNA molecules which encode ... |
|
Dermatophagoides proteins and fragments thereof |
| What is claimed is: 1. An isolated protein comprising an amino acid sequence selected from the ... |
|
Tuberculin active proteins and peptides from the cells of tubercle bacilli |
| What is claimed is: 1. A tuberculin active simple protein from Mycobacterium tuberculosis strain A... |
|
Therapy for injured muscles |
| We claim: 1. A method for treating an injured muscle, the method comprising the step of local ... |
|
Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 1. PRO1560 A cDNA clone (DNA19902-1669) has been identified that encodes a novel polypeptide ... |
|
HIV-specific cytotoxic T-cell responses |
| OF INVENTION The inventors have found that two nanomer peptides, designated CLP-177 (SEQ ID NO:2) ... |
|
|
Self-aligning peptides modeled on human elastin and other fibrous proteins
| Details |
Inventors: Rothstein, Aser; Keely, Fred W.; Rothstein, Steven J.;
Assignee: The Hospital for Sick Children (Toronto, CA); Protein Specialties, Ltd. (Toronto, CA)
Primary Examiner: Tsang; Cecilia J.
Assistant Examiner: Mohamed; Abdel A.
Attorney, Agent or Firm: Foley & Lardner
A polypeptide is provided that has a secondary structure characterized by at least three beta-sheet/beta-turn structures, and that is not a naturally occurring fibrous protein. Such polypeptides, illustrated by one modeled on elastin, are useful in prosthesis. |
|
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS The present invention is directed to unique polypeptides modeled on human elastin and other naturally occurring fibrous proteins. While the discussion below often refers to human elastin as the exemplary parent protein, polypeptides modeled on other naturally occurring fibrous proteins are contemplated by the present invention, and can be made and used in manners analogous to those described for polypeptides modeled on human elastin. The phrase "parent protein" here denotes the protein on which a polypeptide of the invention is modeled. For example, a polypeptide modeled on human elastin comprises a portion of the human tropoelastin amino acid sequence. A "naturally occurring fibrous protein" is any fibrous protein found in nature, where the phrase "fibrous protein" has the conventional meaning in the art. Thus, a fibrous protein is a protein that consists of polypeptide chains arranged in a matrix so as to form long fibers or sheets. See Lehninger, BIOCHEMISTRY 60 (1975). Examples of fibrous proteins include, but are not limited to, elastin, lamprin and spider silk protein. Robson et al. , J. Biol. Chem. 268: 1440-47 (1993), incorporated by reference herein in its entirety, discloses additional proteins on which polypeptides of the present invention may be modeled. Amino acid sequence information is available for elastin and other fibrous extracellular matrix proteins, such as spider silks and lamprin. Together with analyses of secondary and tertiary structures, this information has led to general theories concerning their mechanical properties and, in particular, mechanisms for their assembly into insoluble fibers. Elastin is synthesized in vivo as a monomer called tropoelastin which, upon secretion from the cell, assembles into a branched polymeric network through the formation of covalent crosslinks called desmosines. Mecham et al. , in CELL BIOLOGY OF EXTRACELLULAR MATRIX, 2D ED. (New York, 1991). Desmosine crosslinks are generated enzymically through the action of lysyl oxidase
|
| Related patents |
|
|
Prosthetic devices including elastin or elastin-based materials
It is a specific object of the invention to provide an elastin-based prosthetic device suitable for use as a stent, for example, a vascular stent. The present invention ...
|
|
|
Peptides containing N-substituted L-amino acids for preventing .beta.-strand association
The invention claimed is: 1. A peptide comprising a peptide, wherein: (a) said peptide comprises a .beta.-strand-forming section, said section consisting of four to ...
|
|
|
Lectins and antiretroviral drugs containing the lectins as active ingredient
OF THE INVENTION The lectins of the present invention are obtained from the plants of the class Dicotyledoneae and have a function for inhibiting the reverse ...
|
|
|
Activated dendritic cells and methods for their activation
The present invention pertains to a method of activating dendritic cells to enhance antigen presenting capacity. The activated, antigen-presenting dendritic cells of the ...
|
|
|
Methods and compositions for obtaining mature dendritic cells
OF THE INVENTION This invention relates to methods and compositions useful for promoting the maturation of immature dendritic cells to a mature and stable phenotype as ...
|
|
|
Nucleic acid encoding a lectin-derived progenitor cell preservation factor
It has now been discovered that these and other objectives can be achieved by the present invention, which provides an isolated nucleic acid comprising a nucleotide ...
|
|
|
Ligand for vascular endothelial growth factor receptor
We claim: 1. A compound comprising amino acid sequence Glu-Ile-Glu-Trp-Tyr-Ser-Trp-Val-Thr-His-Gly-Met-Tyr (SEQ ID NO:29). 2. A pharmaceutical composition comprising ...
|
|
|
Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines
What is claimed is: 1. An immunologically active Borrelia burgdorferi protein free of other proteins isolated from Borrelia burgdorferi, which protein comprises SEQ ID NO...
|
|
|
Immunoliposomes that optimize internalization into target cells
The present invention provides novel immunoliposomes optimized for delivering therapeutic agents to the cytoplasm of a target cell. These immunoliposomes exhibit ...
|
|
|
Virus-like particles for the induction of autoantibodies
The inventors have discovered compositions and methods of increasing the titers of antibodies to tolerogens (e.g., self antigens and foreign antigens) over those titers ...
|
|
|